Artiva Biotherapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.70

+0.12 (+1.25%)

As of Jun 30, 10:33 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target -16.1% upside

Low Target $7.28

Average Target $8.14

High Target $10.62

Current Price $9.70

Current
$9.70

Target
$8.14

$7.28 $8.14 avg $10.62

Scenario Analysis

Bear Case

$7.28

-24.9%

Low target

Base Case

$8.14

-16.1%

Avg target

Bull Case

$10.62

+9.5%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$14.53

-33.2% from high

52-Week Low

$1.47

+559.9% from low

Target vs 52W High

$8.14

-44.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%